Stem cell enumeration in cord blood vs bone marrow and peripheral blood.
Recent reports have suggested that the total number of autologous or allogeneic hematopoietic stem cell (HSC) infused after high-dose chemotherapy might predict survival, post-transplant morbidity and rate of hematopoietic engraftment. However, HSC capable of long-term multilineage potential are still poorly defined, and tools for accurate and reproducible HSC enumeration are highly warranted.
Division of Medical Oncology and Experimental Medicine, IRCCS Maugeri Foundation, Pavia Medical Center, Italy.
F
F
Bertolini
M
M
Battaglia
A
A
Lanza
N
N
Gibelli
B
B
Palermo
L
L
Pavesi
G
G
Robustelli della Cuna
D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D015703:Antigens, CD; D018952:Antigens, CD34 / Q000032:analysis; D000943:Antigens, Differentiation / Q000032:analysis; D001772:Blood Cell Count; D001854:Bone Marrow Cells / Q000737:chemistry / Q000166:cytology*; D002469:Cell Separation; D005312:Fetal Blood / Q000737:chemistry / Q000166:cytology*; D005434:Flow Cytometry; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000737:chemistry / Q000166:cytology*; D006801:Humans; D008562:Membrane Glycoproteins; D009244:NAD+ Nucleosidase / Q000032:analysis; D011379:Prognosis
D015703:Antigens, CD; D018952:Antigens, CD34; D000943:Antigens, Differentiation; D008562:Membrane Glycoproteins; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1